Latest Rosalind Advisors, Inc. Stock Portfolio
Rosalind Advisors, Inc. Performance:
2025 Q1: -9.03%YTD: -9.03%2024: 23.89%
Performance for 2025 Q1 is -9.03%, and YTD is -9.03%, and 2024 is 23.89%.
About Rosalind Advisors, Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Rosalind Advisors, Inc. reported an equity portfolio of $205.6 Millions as of 31 Mar, 2025.
The top stock holdings of Rosalind Advisors, Inc. are DCTH, VSTM, XERS. The fund has invested 14.1% of it's portfolio in DELCATH SYS INC and 7.8% of portfolio in VERASTEM INC.
The fund managers got completely rid off CHIMERIX INC (CMRX), CASSAVA SCIENCES INC (SAVA) and OWLET INC (OWLT) stocks. They significantly reduced their stock positions in ALPHA COGNITION INC, TREVI THERAPEUTICS INC (TRVI) and VERONA PHARMA PLC (VRNA). Rosalind Advisors, Inc. opened new stock positions in IDEAYA BIOSCIENCES INC (IDYA), VIRIDIAN THERAPEUTICS INC (VRDN) and NUVATION BIO INC (NUVB). The fund showed a lot of confidence in some stocks as they added substantially to OPTINOSE INC (OPTN), REPLIMUNE GROUP INC (REPL) and TALPHERA INC (ACRX).
The top stock holdings of Rosalind Advisors, Inc. are DCTH, VSTM, XERS. The fund has invested 14.1% of it's portfolio in DELCATH SYS INC and 7.8% of portfolio in VERASTEM INC.
The fund managers got completely rid off CHIMERIX INC (CMRX), CASSAVA SCIENCES INC (SAVA) and OWLET INC (OWLT) stocks. They significantly reduced their stock positions in ALPHA COGNITION INC, TREVI THERAPEUTICS INC (TRVI) and VERONA PHARMA PLC (VRNA). Rosalind Advisors, Inc. opened new stock positions in IDEAYA BIOSCIENCES INC (IDYA), VIRIDIAN THERAPEUTICS INC (VRDN) and NUVATION BIO INC (NUVB). The fund showed a lot of confidence in some stocks as they added substantially to OPTINOSE INC (OPTN), REPLIMUNE GROUP INC (REPL) and TALPHERA INC (ACRX).
Rosalind Advisors, Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Rosalind Advisors, Inc. made a return of -9.03% in the last quarter. In trailing 12 months, it's portfolio return was 9.11%.
New Buys
| Ticker | $ Bought |
|---|---|
| ideaya biosciences inc | 11,466,000 |
| viridian therapeutics inc | 8,020,600 |
| nuvation bio inc | 4,314,640 |
| pharvaris n v | 3,510,940 |
| mind medicine mindmed inc | 2,457,000 |
| cogent biosciences inc | 1,487,230 |
| kura oncology inc | 660,000 |
New stocks bought by Rosalind Advisors, Inc.
Additions
| Ticker | % Inc. |
|---|---|
| optinose inc | 338 |
| optinose inc | 338 |
| replimune group inc | 226 |
| talphera inc | 226 |
| verastem inc | 193 |
| fennec pharmaceuticals inc | 41.51 |
| compass pathways plc | 16.34 |
| delcath sys inc | 9.43 |
Additions to existing portfolio by Rosalind Advisors, Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| alpha cognition inc | -58.52 |
| trevi therapeutics inc | -42.32 |
| verona pharma plc | -33.33 |
| biofrontera inc | -20.63 |
| xeris biopharma holdings inc | -19.61 |
| mediwound ltd | -19.29 |
| myomo inc | -9.85 |
| inspiremd inc | -8.85 |
Rosalind Advisors, Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| chimerix inc | -10,614,000 |
| cassava sciences inc | -985,064 |
| relmada therapeutics inc | -52,000 |
| owlet inc | -220,012 |
Rosalind Advisors, Inc. got rid off the above stocks
Sector Distribution
Rosalind Advisors, Inc. has about 88.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 88.5 |
| Others | 11.5 |
Market Cap. Distribution
Rosalind Advisors, Inc. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MICRO-CAP | 44.4 |
| SMALL-CAP | 34.5 |
| UNALLOCATED | 11.5 |
| MID-CAP | 8.6 |
| NANO-CAP | 1.1 |
Stocks belong to which Index?
About 47% of the stocks held by Rosalind Advisors, Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 53 |
| RUSSELL 2000 | 47 |
Rosalind Advisors, Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Rosalind Advisors, Inc.
Rosalind Advisors, Inc. has 32 stocks in it's portfolio. About 63.4% of the portfolio is in top 10 stocks. DCTH proved to be the most loss making stock for the portfolio. XERS was the most profitable stock for Rosalind Advisors, Inc. last quarter.
Last Reported on: 14 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics inc | 4.18 | 1,805,820 | 8,595,690 | added | 0.02 | ||
| ACRX | talphera inc | 0.48 | 2,003,940 | 991,950 | added | 226 | ||
| BFRI | biofrontera inc | 0.25 | 644,393 | 515,514 | reduced | -20.63 | ||
| CMPS | compass pathways plc | 1.15 | 823,286 | 2,354,600 | added | 16.34 | ||
| CMRX | chimerix inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| COGT | cogent biosciences inc | 0.72 | 248,285 | 1,487,230 | new | |||
| CYBN | cybin inc | 2.50 | 810,918 | 5,141,220 | unchanged | 0.00 | ||
| DCTH | delcath sys inc | 14.10 | 2,900,390 | 29,003,900 | added | 9.43 | ||
| FENC | fennec pharmaceuticals inc | 5.28 | 1,782,840 | 10,857,500 | added | 41.51 | ||
| IDYA | ideaya biosciences inc | 5.58 | 700,000 | 11,466,000 | new | |||
| KALV | kalvista pharmaceuticals inc | 1.71 | 303,864 | 3,506,590 | unchanged | 0.00 | ||
| KPRX | kiora pharmaceuticals inc | 0.37 | 250,059 | 752,678 | reduced | -0.2 | ||
| KURA | kura oncology inc | 0.32 | 100,000 | 660,000 | new | |||
| MNMD | mind medicine mindmed inc | 1.20 | 420,000 | 2,457,000 | new | |||
| MYO | myomo inc | 6.32 | 2,703,660 | 13,004,600 | reduced | -9.85 | ||
| NSPR | inspiremd inc | 2.98 | 2,274,990 | 6,119,720 | reduced | -8.85 | ||
| NUVB | nuvation bio inc | 2.10 | 2,451,500 | 4,314,640 | new | |||
| OCUL | ocular therapeutix inc | 4.34 | 1,218,700 | 8,933,070 | added | 7.97 | ||
| OPTN | optinose inc | 1.14 | 256,190 | 2,349,260 | added | 338 | ||
| OWLT | owlet inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||